0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessGerhardt Attard, Neeraj Agarwal, Julie N. Graff, Shahneen Sandhu, Eleni Efstathiou, Mustafa Özgüroğlu, Andrea Juliana Gomes, Karina Vianna, Hong Luo, Geoffrey Gotto, Heather H. Cheng, Won Bae Kim, Carly R. Varela, Daneen Schaeffer, K. Krämer, Susan Li, Benoît Baron, Fei Shen, Suneel Mundle, Sharon McCarthy, David Olmos, Kim N., Dana E. Rathkopf (2025). Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial. , 31(12), DOI: https://doi.org/10.1038/s41591-025-03961-8.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2025
Authors
23
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1038/s41591-025-03961-8
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
